New wearable patch could track kidney health in real time

NCT ID NCT07632469

Not yet recruiting Diagnosis Sponsor: Bin Du Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a wearable device that continuously measures kidney function in ICU patients with acute kidney injury (AKI). The device uses a fluorescent tracer and a chest patch to track GFR in real time. Researchers will compare its accuracy to standard lab tests in 50 adults. If it works, it could offer a simpler, non-invasive way to monitor kidney health in critically ill patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transdermal GFR monitoring device (with Lumitrace fluorescent tracer)
What this could lead to: If successful, this could provide a non-invasive, continuous way to monitor kidney function in critically ill patients, potentially improving AKI management.
What could go wrong: This is a small, early-phase study (50 participants) focused on accuracy, not treatment. The device may not prove reliable enough for routine use, and results may not apply to all AKI patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AKI are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AKI GFR

More trials for these conditions

Other studies related to the condition(s) this trial covers.